
Researchers from the Academic Medical Center, Amsterdam, The
Netherlands presented the first evidence of a scavenger receptor class
B1 (SR-B1) mutation in man. SR-B1 is a hepatic receptor that promotes
selective uptake and removal of HDL from the plasma, and is therefore
important in protecting against atherosclerosis.